Ovarian epithelial cancer – Life with Disease

Go back

Ovarian epithelial cancer represents the most common form of ovarian malignancy, developing in the tissue surrounding the ovaries, fallopian tubes, or the lining of the abdominal cavity. While this disease often presents challenges due to late detection, understanding its progression, complications, and impact on daily life can help patients and families navigate the journey ahead with greater confidence and support.

Prognosis and Outlook

The outlook for ovarian epithelial cancer varies widely depending on when the disease is discovered and how the body responds to treatment. Unfortunately, this cancer is often difficult to detect early because symptoms tend to be subtle or absent in the beginning stages. According to medical experts, more than half of ovarian cancer diagnoses occur in women over 65 who have gone through menopause.[1]

Nearly 70 percent of high-grade serous ovarian cancer cases—the most common and aggressive subtype—are diagnosed at stage 3 or 4, meaning the cancer has already spread to nearby organs and lymph nodes.[1] When ovarian epithelial cancer is detected at an advanced stage, the outlook becomes more challenging. However, this does not mean there is no hope. Many women respond well to initial treatments, and advances in therapy continue to improve outcomes.

The overall survival rate for ovarian cancer is about 50 percent at five years after diagnosis. However, when the disease is caught early—before it spreads beyond the ovaries—the five-year survival rate can reach approximately 93 percent with aggressive treatment.[7] These statistics highlight the critical importance of early detection, though they are only general estimates. Every person’s situation is unique, and survival depends on many factors including the cancer’s stage, type, grade, how well treatment works, and overall health and fitness.

Your doctor is the best person to discuss your individual outlook. They have access to all the details about your specific cancer and can provide a more personalized estimate based on their experience caring for people with similar conditions. Some women may not want to know detailed statistical information immediately, and that is completely normal. You can always ask for more information when you feel ready.[19]

⚠️ Important
Not everyone wants to ask about how long they will live, and that is completely understandable. However, if you feel you need this information to plan or make decisions, do ask your specialist doctor. They won’t be able to give an exact answer, but they can provide an estimated timeframe based on their clinical experience. Remember that everyone is different, and no one can say exactly how long any individual will live.

Treatment can sometimes control the cancer and relieve symptoms for many months and even years, depending on your situation. If you are very unwell or cannot have further treatment, the timeframe may be shorter. Understanding these realities, while difficult, can help you and your loved ones make informed decisions about care and how you want to spend your time.[19]

Natural Progression of the Disease

If ovarian epithelial cancer is left untreated, it will continue to grow and spread. Experts believe that many ovarian cancers actually start in cells at the very end of the fallopian tubes, particularly in the area called the fimbriae. These early cancer cells then spread to the ovary and begin to grow more rapidly once they reach that location.[1]

In the early stages, epithelial ovarian cancer may grow slowly. High-grade serous carcinoma, for example, is thought to develop gradually at first in the fallopian tubes. However, once the cancer reaches the ovaries, it can spread much more quickly.[1] The natural course of untreated ovarian cancer involves spreading into the abdominal cavity, a process called peritoneal spread. Cancer cells can implant themselves on the uterus, intestines, bladder, or the omentum—a fatty tissue that covers the abdominal organs.[7]

As the disease advances, fluid begins to accumulate in the abdomen, a condition known as ascites. This fluid buildup causes noticeable symptoms like abdominal bloating, swelling, and pain. Sometimes, ovarian cancer cells spread through the bloodstream or lymphatic system, reaching other parts of the body such as the lungs.[1][7]

Without treatment, symptoms become more severe over time. What may have started as mild bloating or digestive discomfort progresses to persistent abdominal pain, difficulty eating, nausea, and significant changes in bowel or urinary habits. The cancer’s spread to other organs can cause breathing difficulties, fatigue, and weight loss. Eventually, the disease interferes with vital organ function, leading to serious complications.

Possible Complications

Ovarian epithelial cancer can lead to several complications as it advances, affecting both the cancer itself and the body’s ability to function normally. Understanding these complications helps patients and families prepare for potential challenges and seek appropriate medical support.

One common complication is the accumulation of fluid in the abdomen, called ascites. As cancer spreads into the peritoneum—the tissue lining the abdominal cavity—it causes inflammation and fluid buildup. This creates uncomfortable bloating, pressure, and pain. In severe cases, ascites can make breathing difficult because the fluid pushes against the diaphragm and restricts lung expansion.

Bowel obstruction is another serious complication. When cancer spreads to the intestines or grows large enough to press against them, it can block the normal passage of food and waste. This causes severe abdominal pain, nausea, vomiting, and constipation. Bowel obstructions may require emergency medical intervention and sometimes surgery to relieve the blockage.

Cancer that spreads to the lungs can cause a complication called pleural effusion, where fluid builds up in the space around the lungs. This leads to shortness of breath, chest pain, and persistent coughing. Fluid may need to be drained through a medical procedure to help with breathing.[7]

Blood clots are also a significant risk. Cancer increases the likelihood of developing clots in the legs (deep vein thrombosis) or lungs (pulmonary embolism). These clots can be life-threatening if not treated promptly. Signs include leg swelling, pain, sudden shortness of breath, and chest pain.

As the disease progresses, severe weight loss and malnutrition can develop. This happens because the cancer affects appetite, causes nausea, or prevents proper digestion and absorption of nutrients. The body may also use more energy fighting the disease, leading to unintentional weight loss and weakness.

Kidney problems can arise if tumors press on or block the ureters—the tubes that carry urine from the kidneys to the bladder. This can lead to kidney damage or infection if left untreated. Pain and infection are additional complications that require ongoing management. Cancer itself can cause pain as it grows and presses on nerves or organs. Secondary infections may develop because cancer and its treatments can weaken the immune system.

Impact on Daily Life

Living with ovarian epithelial cancer affects nearly every aspect of daily life, from physical abilities to emotional well-being, social relationships, and work. Understanding these impacts can help patients develop coping strategies and seek appropriate support.

Physically, the disease and its treatment can cause significant fatigue, which is often described as an overwhelming tiredness that doesn’t improve with rest. This exhaustion can make even simple tasks like getting dressed, preparing meals, or walking short distances feel overwhelming. Chemotherapy, which is a common treatment, can cause additional side effects including nausea, hair loss, changes in taste, numbness in hands and feet, and a weakened immune system that increases infection risk.[22]

Many women experience changes in appetite and eating habits. Treatment side effects like nausea, mouth sores, or changes in taste can make eating unpleasant or difficult. Bloating from the cancer itself or ascites may cause feelings of fullness after eating only small amounts. Maintaining good nutrition becomes challenging but remains important for strength and healing.[22]

Physical activity often decreases due to fatigue, pain, or treatment side effects. However, research has shown that staying physically active—even with gentle activities like short walks—can actually help reduce symptoms like anxiety, fatigue, and insomnia. Exercise has been shown to be beneficial during and after treatment, though it’s important to discuss appropriate activity levels with your healthcare team.[23]

Emotionally, an ovarian cancer diagnosis can feel overwhelming. It’s completely normal to experience a wide range of feelings including shock, fear, anger, sadness, or anxiety. Many women struggle with uncertainty about the future, worries about treatment, and concerns about how the disease will affect their family. These emotional responses are natural reactions to a life-changing diagnosis.

Some women find it difficult to think about anything other than their cancer, especially in the period right after diagnosis. Others may feel numb or detached. There is no right or wrong way to feel. Talking with a counselor, joining a support group, or connecting with other women who have faced similar challenges can provide emotional relief and practical coping strategies.[1]

Social relationships may change during treatment. Some friends and family members may not know how to respond or what to say, which can feel isolating. Others may offer overwhelming amounts of advice or help. Open communication about what you need—whether it’s practical help, companionship, or simply space—can help maintain important relationships during this difficult time.

Work life is often disrupted by treatment schedules, medical appointments, and physical limitations. Some women can continue working during treatment, perhaps with modifications or reduced hours. Others need to take medical leave. Financial concerns about lost income, treatment costs, and insurance coverage add another layer of stress to an already challenging situation.

Intimate relationships and sexuality are also affected. Treatment can cause physical changes like vaginal dryness, pain during intercourse, or loss of libido. Surgical removal of reproductive organs and the emotional impact of diagnosis can affect how women feel about their bodies and femininity. Open, honest communication with partners and healthcare providers can help address these sensitive but important concerns.

⚠️ Important
Many women with ovarian cancer experience physical symptoms such as bloating, fatigue, and changes in appetite that significantly affect daily activities. However, research suggests that staying physically active after diagnosis—even with gentle exercise—and avoiding smoking can help improve outcomes. Always discuss appropriate activity levels and lifestyle changes with your healthcare team before making major changes.

Despite these challenges, many women find ways to adapt and maintain quality of life. Some discover new priorities or make time for activities they previously postponed. Setting small, achievable goals for each day can help maintain a sense of control and accomplishment. Accepting help from others, being flexible with expectations, and focusing on what you can control rather than what you cannot are all valuable coping strategies.[22]

Support for Family Members

When a loved one is diagnosed with ovarian epithelial cancer, family members often feel helpless and uncertain about how to help. However, families play a crucial role in supporting patients through diagnosis, treatment, and beyond. Understanding what your loved one is facing and how you can provide meaningful support makes a significant difference in their journey.

One important area where families can help is in understanding and exploring clinical trials. Clinical trials are research studies that test new treatments or combinations of treatments to see if they work better than standard care. For ovarian cancer, many clinical trials are underway testing innovative approaches including new targeted therapies, immunotherapies, and treatment combinations.[12]

Family members should know that participating in a clinical trial is always voluntary and may offer access to promising new treatments before they become widely available. However, clinical trials also involve some uncertainty since the treatments are still being studied. Not every patient is eligible for every trial, as each study has specific requirements about cancer stage, prior treatments, and overall health.

Families can help their loved one research clinical trials by looking at reliable sources such as the National Cancer Institute’s clinical trial database or speaking with the oncology team about available options. The patient’s doctor is the best resource for determining whether a specific trial might be appropriate and can explain the potential benefits and risks.[3]

If your loved one is considering a clinical trial, you can help by taking notes during medical appointments, asking questions about how the trial works, understanding what the treatment involves, and learning about potential side effects. Help organize information about different trials and support your loved one in making the decision that feels right for them.

Beyond clinical trials, families can provide practical support in many ways. Accompanying your loved one to medical appointments provides both practical help and emotional comfort. Taking notes during these visits ensures important information isn’t forgotten. Help with transportation to and from treatments, especially chemotherapy appointments which can leave patients feeling unwell, is invaluable.

Assistance with daily tasks becomes increasingly important during treatment. Preparing meals, grocery shopping, cleaning, caring for children or pets, and managing household responsibilities allows the patient to conserve energy for healing. Even small gestures like picking up prescriptions or organizing medications can reduce stress and burden.

Emotional support is equally important as practical help. Simply being present, listening without judgment, and allowing your loved one to express their fears and frustrations provides comfort. Some days they may want to talk about their cancer; other days they may prefer to focus on other topics. Follow their lead and respect their wishes about how much they want to discuss their condition.

Learn about the disease and its treatment so you can better understand what your loved one is experiencing. However, avoid overwhelming them with unsolicited advice or stories about other people’s cancer experiences. Every case is different, and what worked for someone else may not be relevant or helpful.

Take care of your own emotional and physical health as well. Supporting someone with cancer is emotionally demanding. It’s not selfish to take breaks, seek your own support through counseling or support groups for caregivers, and maintain activities that help you recharge. You’ll be better able to support your loved one if you’re not depleted yourself.

Encourage your loved one to communicate openly with their healthcare team about symptoms, side effects, or concerns. Sometimes patients hesitate to “bother” their doctors with questions. Assure them that their medical team wants and needs to know about any problems so they can provide the best care possible.

Financial and insurance matters can be overwhelming. Help your loved one understand their insurance coverage, organize medical bills, and research financial assistance programs if needed. Many hospitals have financial counselors or social workers who can provide guidance about resources for patients facing financial hardship due to cancer treatment.

Remember that the best support is often simply showing up, being present, and letting your loved one know they don’t have to face this journey alone. Your consistent presence and willingness to help in whatever way is needed provides immeasurable comfort during an incredibly difficult time.

💊 Registered drugs used for this disease

List of officially registered medicines that are used in the treatment of this condition, based only on the provided sources:

  • Carboplatin – A platinum-based chemotherapy drug used as first-line treatment for ovarian epithelial cancer, often combined with paclitaxel
  • Paclitaxel – A taxane-based chemotherapy drug commonly used in combination with carboplatin as standard first-line treatment
  • Bevacizumab (Avastin®) – A monoclonal antibody that targets the VEGF/VEGFR pathway and inhibits tumor blood vessel growth; approved for patients with newly-diagnosed and relapsed ovarian cancer
  • Mirvetuximab soravtansine (Elahere™) – An antibody-drug conjugate that targets the folate receptor pathway and delivers toxic drugs to tumors; approved for subsets of patients with advanced ovarian cancer
  • Dostarlimab (Jemperli) – A checkpoint inhibitor that targets the PD-1/PD-L1 pathway; approved for subsets of patients with advanced ovarian cancer that has DNA mismatch repair deficiency (dMMR)
  • Pembrolizumab (Keytruda®) – A checkpoint inhibitor that targets the PD-1/PD-L1 pathway; approved for subsets of patients with advanced ovarian cancer that has high microsatellite instability (MSI-H) or DNA mismatch repair deficiency
  • PARP inhibitors – A class of drugs that block DNA repair in cancer cells; used as maintenance therapy particularly for patients with BRCA1 or BRCA2 gene mutations

Ongoing Clinical Trials on Ovarian epithelial cancer

  • Study of JK06 for Patients with Advanced or Metastatic Cancer

    Recruiting

    2 1 1
    Investigated drugs:
    Belgium Spain
  • Study on Hyperthermic Intraperitoneal Chemotherapy with Cisplatin for Patients with Recurrent Ovarian Cancer

    Recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    France
  • Study on Adjusting Chemotherapy with Carboplatin and Paclitaxel for Patients with Poor Prognostic Ovarian Cancer

    Recruiting

    3 1 1 1
    France Italy The Netherlands
  • Study on the Safety and Effectiveness of GTAEXS617 for Patients with Advanced Solid Tumors

    Recruiting

    2 1 1 1
    Belgium
  • Study of ETX-19477 for Patients with Advanced Solid Tumors After Standard Treatment

    Not yet recruiting

    2 1 1
    Investigated diseases:
    Investigated drugs:
    France Italy Spain
  • Study of Mirvetuximab Soravtansine and Bevacizumab for Maintenance in Adults with Recurrent Platinum-Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

    Not yet recruiting

    3 1 1 1
    Belgium Bulgaria Czechia France Germany Greece +5
  • Study of Rucaparib and Nivolumab for Maintenance Treatment in Patients with Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cancer After Chemotherapy

    Not recruiting

    3 1 1
    Investigated drugs:
    Belgium Czechia Denmark Germany Greece Ireland +5
  • Study on the Effectiveness and Safety of Cyclophosphamide Monohydrate and Drug Combination for Patients with Persistent or Recurrent Rare Epithelial Ovarian Tumors

    Not recruiting

    2 1 1 1
    Investigated diseases:
    Czechia France Germany Italy Spain
  • Study on Niraparib’s Effects and Safety in Patients with High-Grade Serous Ovarian Cancer

    Not recruiting

    3 1 1 1
    Investigated diseases:
    France
  • Study of Chemotherapy With Pembrolizumab and Olaparib for Patients With Advanced Epithelial Ovarian Cancer Without BRCA Mutation

    Not recruiting

    3 1 1
    Investigated diseases:
    Belgium Czechia France Germany Hungary Italy +2

References

https://my.clevelandclinic.org/health/diseases/22250-epithelial-ovarian-cancer

https://www.ncbi.nlm.nih.gov/books/NBK567760/

https://www.cancer.gov/types/ovarian/patient/ovarian-epithelial-treatment-pdq

https://www.cancerresearchuk.org/about-cancer/ovarian-cancer/types/epithelial-ovarian-cancer

https://www.mayoclinic.org/diseases-conditions/ovarian-cancer/symptoms-causes/syc-20375941

https://www.loyolamedicine.org/services/cancer/cancer-conditions/ovarian-cancer/ovarian-epithelial-cancer

https://www.ebsco.com/research-starters/health-and-medicine/ovarian-epithelial-cancer

https://vicc.org/cancer-info/adult-ovarian-epithelial-fallopian-tube-and-primary-peritoneal-cancer

https://www.cancer.gov/types/ovarian/patient/ovarian-epithelial-treatment-pdq

https://pubmed.ncbi.nlm.nih.gov/33168565/

https://www.cancer.org/cancer/types/ovarian-cancer/treating.html

https://cancerblog.mayoclinic.org/2024/05/01/ovarian-cancer-new-treatments-and-research/

https://jeccr.biomedcentral.com/articles/10.1186/1756-9966-31-14

https://www.ncbi.nlm.nih.gov/books/NBK567760/

https://www.cancer.gov/types/ovarian/hp/ovarian-epithelial-treatment-pdq

https://www.cancerresearch.org/immunotherapy-by-cancer-type/ovarian-cancer

https://my.clevelandclinic.org/health/diseases/22250-epithelial-ovarian-cancer

https://www.cancer.northwestern.edu/types-of-cancer/gynecologic/ovarian.html

https://www.cancerresearchuk.org/about-cancer/ovarian-cancer/living-with/coping-if-your-cancer-cant-be-cured

https://www.myovariancancerteam.com/resources/what-you-need-to-know-about-epithelial-ovarian-cancer-symptoms-treatment-and-prognosis

https://www.cancer.org/cancer/types/ovarian-cancer/after-treatment.html

https://www.everydayhealth.com/ovarian-cancer/everyday-guide-to-living-well/

https://www.obermair.info/latest-news/blog/a-healthy-lifestyle-after-ovarian-cancer-diagnosis-may-help-women-improve-their-prognosis/

FAQ

What are the early warning signs of ovarian epithelial cancer?

Ovarian epithelial cancer rarely causes noticeable symptoms in early stages. As it progresses, symptoms include abdominal bloating, pain, difficulty eating or feeling full quickly, nausea, pelvic pain, changes in bowel habits, frequent urination, and sometimes vaginal bleeding. These symptoms can be easily mistaken for common digestive issues, which is why the cancer is often detected late.

What causes ovarian epithelial cancer?

The exact cause of ovarian epithelial cancer is unknown. Experts believe it often starts in cells at the end of the fallopian tubes and then spreads to the ovaries. Risk factors include family history of ovarian cancer, inherited gene mutations (especially BRCA1 and BRCA2), older age (over 65), endometriosis, obesity, postmenopausal hormone therapy, and having had breast or colon cancer.

How is ovarian epithelial cancer diagnosed?

Diagnosis typically begins with a thorough physical and pelvic exam where the doctor feels for abnormal areas. Imaging tests such as ultrasound, transvaginal ultrasound, MRI, CT scan, or PET scan may be ordered. A blood test called CA-125 assay checks for a cancer marker. The definitive diagnosis comes from a biopsy, where tissue is removed and examined in a laboratory to confirm the presence of cancer cells.

What treatment options are available for ovarian epithelial cancer?

Standard treatment includes surgery to remove as much of the tumor as possible (called debulking surgery or cytoreductive surgery), followed by chemotherapy using a combination of carboplatin and paclitaxel. Other treatments may include targeted therapies like bevacizumab, PARP inhibitors for maintenance therapy, immunotherapy drugs like pembrolizumab or dostarlimab for certain patients, and radiation therapy in some cases.

Can lifestyle changes improve my prognosis with ovarian cancer?

Research suggests that certain lifestyle factors after diagnosis may help improve outcomes. Quitting smoking and maintaining physical activity are associated with better survival. Exercise during and after treatment can reduce side effects like fatigue, anxiety, and insomnia while improving quality of life. A balanced diet with fruits, vegetables, and lean proteins supports nutrition during treatment, though no specific diet has been proven to cure cancer or prevent recurrence.

🎯 Key takeaways

  • Ovarian epithelial cancer accounts for about 90 percent of all ovarian cancer diagnoses and is the most lethal gynecologic malignancy
  • Nearly 70 percent of high-grade serous ovarian cancer cases are diagnosed at stage 3 or 4, when cancer has already spread to nearby organs
  • Many experts now believe most ovarian cancers actually start in the fallopian tubes, not the ovaries themselves
  • The five-year survival rate is approximately 93 percent when detected early, but drops to about 50 percent overall due to late detection
  • Women with BRCA1 or BRCA2 gene mutations face significantly higher lifetime risk of developing ovarian cancer
  • New targeted therapies including bevacizumab, PARP inhibitors, and immunotherapy drugs are improving outcomes and survival rates
  • Staying physically active after diagnosis and avoiding smoking may help improve prognosis and reduce treatment side effects
  • Clinical trials offer access to promising new treatments and represent an important option for many patients to consider